Rethinking Menopause Hormone Therapy - Top_Thought_Leaders - MDSpire

Rethinking Menopause Hormone Therapy

A JAMA Perspective outlines how updated FDA labeling may reshape menopause care.

  • By

  • Kerri Miller

  • April 23, 2026

  • 3 min

Share

Top Thought Leaders in General Medicine

Brief introduction explaining scope and methodology.

Original Source(s)

Rethinking Menopause Hormone Therapy

  • by Kerri Miller

  • April 23, 2026

Related Content

Federal appeals court blocks mailing of abortion pill mifepristone

Former FDA leaders, pharma speak out on mifepristone

Birthweight, Childhood BMI: What Drives the Link?

Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.